More on VINC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.87 |
|
|||
| Open | $0.87 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.99 | ||||
| Day Low | $0.87 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 415,974 | ||||
- Form ARS Vincerx Pharma, Inc. For: Dec 31
- Form DEFA14A Vincerx Pharma, Inc.
- Form DEF 14A Vincerx Pharma, Inc. For: May 23
- Form SC 13G/A Vincerx Pharma, Inc. Filed by: GOLDMAN SACHS GROUP INC
- Form 8-K Vincerx Pharma, Inc. For: Apr 08
- Vincerx Pharma (VINC) Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress
- Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
- Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
- Vincerx Pharma, Inc. (VINC) Tops Q4 EPS by 14c
- Form 8-K Vincerx Pharma, Inc. For: Mar 29
Entities mentioned with VINC
- 13G | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- S3 | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Goldman Sachs | View Related Stories »
- Deerfield Management | View Related Stories »
- Show More...
